News about Global Pharma

Akums Drugs & Pharmaceuticals Embraces Sustainability with Rooftop Solar Plant in its Haridwar Warehouse

Akums Drugs & Pharmaceuticals Embraces Sustainability with Rooftop Solar Plant in its Haridwar Warehouse

Akums Drugs & Pharmaceuticals Ltd. has installed a 600 kWp rooftop solar power plant at its warehouse in Haridwar, Uttarakhand marking a major step in its commitment to sustainability and clean energy adoption.

Global Pharma | 11/04/2025 | By Manvi 626

Innoblative Wins FDA IDE Approval for SIRA Device, Advancing Breast Cancer Surgery Innovation

Innoblative Wins FDA IDE Approval for SIRA Device, Advancing Breast Cancer Surgery Innovation

Innoblative's SIRA device is a single-use, disposable applicator built for intraoperative ablation of the post-lumpectomy cavity during breast conserving surgery.

Global Pharma | 11/04/2025 | By Abha 572

Novartis Unveils USD 23 Billion US Investment to Boost Domestic Drug Manufacturing and Research

Novartis Unveils USD 23 Billion US Investment to Boost Domestic Drug Manufacturing and Research

Over the next 5 years, Novartis will establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US.

Global Pharma | 11/04/2025 | By Abha 721

Biocon Biologics Announces USFDA Approval of JOBEVNE Biosimilar for Cancer Treatment

Biocon Biologics Announces USFDA Approval of JOBEVNE Biosimilar for Cancer Treatment

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd announced that the US Food and Drug Administration (USFDA) has approved Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use.

Global Pharma | 10/04/2025 | By Manvi 470

OneSource Receives Approval from Brazilian Health Regulatory Agency for its Flagship Facility in Bengaluru

OneSource Receives Approval from Brazilian Health Regulatory Agency for its Flagship Facility in Bengaluru

OneSource Specialty Pharma’s flagship Unit 2 facility in Bengaluru has received GMP certification from Brazil's ANVISA, enabling it to supply high-quality biologics and drug-device combinations to the Brazilian market.

Global Pharma | 10/04/2025 | By Manvi 362

Eko Health Launches CORE 500 Digital Stethoscope and Eko+ Membership in Canada

Eko Health Launches CORE 500 Digital Stethoscope and Eko+ Membership in Canada

Eko Health announced the launch of the CORE 500™ Digital Stethoscope and Eko+ Membership in Canada. This expansion follows Health Canada approval of the CORE 500 Digital Stethoscope and Eko+, making it available to Canadian clinicians seeking advanced digital auscultation technology to support cardiac and pulmonary care.

Global Pharma | 10/04/2025 | By Manvi 612

Orexo's AmorphOX Technology Demonstrates Success in Formulating Powder-Based Intranasal Influenza Vaccine

Orexo's AmorphOX Technology Demonstrates Success in Formulating Powder-Based Intranasal Influenza Vaccine

The collaboration aims to develop mucosal vaccines by combining Orexo's powder-based drug delivery technology AmorphOX with Abera's innovative and patented vaccine platform BERA™.

Global Pharma | 10/04/2025 | By Abha 353

B. Braun Medical Receives FDA Approval for Piperacillin, Tazobactam in DUPLEX Drug Delivery System

B. Braun Medical Receives FDA Approval for Piperacillin, Tazobactam in DUPLEX Drug Delivery System

Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is a ready-to-activate, two-compartment container that keeps pre-measured medication and diluent separate until the provider is ready to administer at the bedside by simply folding, squeezing, and shaking to reconstitute.

Global Pharma | 10/04/2025 | By Abha 650

EssilorLuxottica Announces US Launch of Nuance Audio Glasses

EssilorLuxottica Announces US Launch of Nuance Audio Glasses

Paving the way for a disruptive new category in the med-tech space, Nuance Audio Glasses are FDA-registered over-the-counter (OTC) hearing aids, allowing consumers to address their hearing needs without requiring a prescription or an audiologist visit. A

Global Pharma | 09/04/2025 | By Manvi 697

ZIM Labs and Globalpharma Collaborate to Commercialise Oral Thin Film Products in GCC Region

ZIM Labs and Globalpharma Collaborate to Commercialise Oral Thin Film Products in GCC Region

ZIM Laboratories has partnered with UAE-based Globalpharma to license its proprietary Oral Thin Film technology and supply products for regional commercialisation, expanding its footprint in the Middle Eastern pharmaceutical market.

Global Pharma | 09/04/2025 | By Manvi 385

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members